Bloomberg News reported that GlaxoSmithKline P.L.C. has agreed to pay $1 billion to injured consumers to resolve more than 800 cases involving the antidepressant Paxil. The medication has been in use in the U.S. since 1992. Paxil generated about $793 million in sales in 2009 alone which was about 1.8 percent of Glaxo’s total revenue. Glaxo reported U.S. sales exceeding $11 billion since 1997.

Please see full article below for more information.